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ABSTRACT
Activation of protease activated-receptor 1 (PAR-1) has been shown to decrease
motoneuron survival.  This G protein receptor is activated when thrombin cleaves the original
NH2-terminus generating a new sequence that binds to and activates a transmembrane receptor
portion. However, the signaling pathway following motoneuron PAR-1 activation has not
been elucidated.  Research suggests that a calcium set point, a balance between Ca2+i and
neurotrophic factors, is necessary for motoneuron survival.  The first study hypothesized
that PAR-1 activated motoneuron death in vitro would correspond with increased levels of
Ca2+i.  In addition, motoneuron death often results in the concurrent loss of target muscle
cells, which are a known source of neurotrophic factors.  However, such an event would
induce a greater degree of motoneuron cell death than we had previously observed.  Therefore,
the second study hypothesized that PAR-1 activation in vivo would not affect skeletal muscle
cell survival.  A Tukey’s post-hoc test of the Ca2+i assay did not support the hypothesis that
PAR-1 activation would lead to increased Ca2+i.  However, histological studies did support
the hypothesis that in vivo activation of PAR-1 does not alter the number of surviving skeletal
muscle cells.  Quantitative western blot analysis of neurotrophic factors did not detect any
differences in their levels before or after PAR-1 activation. Taken together, these data suggest
that Ca2+i does not serve as a second messenger in the cell death pathway following activation
of avian motoneuron PAR-1, while target skeletal muscle cells and potential levels of muscle
derived growth factors are unaltered.
INTRODUCTION
One known trigger of neuronal apoptosis is thrombin, a serine protease whose most-
understood role is the conversion of fibrinogen to fibrin during the coagulation cascade
(Esmon, 1993). However, mRNA for prothrombin, thrombin’s zymogen precursor, has been
localized within the developing nervous system, suggesting that thrombin is produced
(Dihanich et al., 1991) and is functional (for reviews see Suidan et al., 1992; Turgeon et al.,
2000) within the nervous system itself.  Thrombin has been shown to cause apoptosis in
avian motoneurons, both in vitro (Turgeon et al., 1998) and in vivo (Turgeon et al., 1999),
and to induce neurite retraction (Gurwitz and Cunningham, 1988; Suidan et al., 1992) through
activation of a cell surface thrombin receptor.
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To date, several thrombin receptors have been identified, and these receptors are all
members of a family of membrane proteins known as protease-activated receptors (PARs).
Thrombin has been shown to activate both PAR-1 and PAR-3, while another serine protease,
trypsin, has been shown to primarily activate PAR-2 (Déry et al., 1998; Ubl et al., 1998).
Furthermore, both thrombin and trypsin have been shown to activate PAR-4 (Xu et al.,
1998).  Each of these receptors has a seven-transmembrane domain and is activated by a
tethered ligand.  The protease, itself, does not directly activate the receptor; instead, it cleaves
the extracellular amino terminus exposing a new amino terminus that undergoes a
conformational change allowing it to bind to another region within its own receptor, thus
activating it (Vu et al., 1991).  All PARs are classified as G protein-linked and the subsequently
activated second messenger depends on the specific PAR (Kanthou and Benzakour, 1995).
While PARs are present in many cell types throughout the vertebrate body, studies relevant
to this project have established that both PAR-1 (Turgeon et al., 1999) and its mRNA (Niclou
et al., 1994) are present within the vertebrate nervous system.
The amino acid sequence of PAR-1’s tethered ligand is serine-phenylalanine-leucine-
leucine-arginine-asparagine-proline (SFLLRNP) (Vu et al., 1991). The addition of a tethered
ligand sequence has the ability to activate its cognate receptor without cleaving the original
receptor (Vu et al., 1991) so that use of these sequences is beneficial to determine the activation
of a specific PAR.  For example, the addition of SFLLRNP has been shown to mimic the
neurodegenerative effects of thrombin on motoneurons in vitro (Turgeon et al., 1998) and in
vivo (Turgeon et al., 1999).   Since PAR-1 is known to be activated only by this specific
peptide, these studies provide strong evidence that PAR-1 is indeed the receptor by which
thrombin initiates the cell death process in motoneurons. Because PARs are known to activate
a variety of G protein subunits, multiple second messenger pathways are possible and within
different cell types PAR activation may produce different responses (Déry et al., 1998).
Activation of motoneuron PAR-1 by thrombin has been shown to initiate apoptosis,
presumably through activation of the caspase cascade (Turgeon et al., 1998).  However, the
specific intracellular signaling pathway linking PAR-1 to caspase activation in neuronal
apoptosis is unknown.  While PAR-1 has been shown to activate different second messengers
depending on the cell type the most plausible second messenger pathway is the phospholipase
C (PLC)/inositol triphosphate (IP3) cascade through which IP3 leads to increased levels of
intracellular calcium (Ca2+i) and protein kinase C (Nichols et al., 2001).
Tong et al. (1996) demonstrated that below-normal concentrations of Ca2+i in cultured
sensory neurons led to apoptosis, which was preventable by the addition of nerve growth
factor (NGF) that raised the Ca2+i concentration back to normal.  This research led to the
formulation of the calcium set-point hypothesis, which proposes that normal levels of Ca2+i
suppress the cell death pathway, while low levels of Ca2+i necessitate that growth factors be
present to override the apoptosis signal (Tong et al., 1996).  In support of this hypothesis,
Koike and Tanaka (1991) showed that sympathetic neurons also depend on increased Ca2+i
concentrations in the absence of NGF.  Furthermore, Smith-Swintosky et al. (1995b)
demonstrated that abnormally high Ca2+i concentrations corresponded with thrombin-induced
cell death in hippocampal neurons, which correlated thrombin-induced cell death with changes
in Ca2+i concentrations.  The researchers modified the calcium set-point hypothesis by
suggesting that abnormally high, as well as abnormally low, Ca2+i concentrations contributed
to neuronal cell death.
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Complicating the understanding of the signaling process is the role of the myriad growth
factors that influence the vertebrate nervous system.  The neurotrophic hypothesis states
that neuronal survival depends on access to neurotrophic factors (Houenou and Oppenheim,
1994).  Research has also shown that certain neurotrophic factors (NTFs) can at least partially
rescue motoneurons from apoptosis after thrombin exposure in vitro (Turgeon and Houenou,
1999) and after axotomy in vivo (Oppenheim et al., 1995).  These growth factors include
brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF),
and ciliary neurotrophic factor (CNTF).  Both BDNF and CNTF are synthesized by the
skeletal muscle targets and have been shown to inhibit the effects of PAR-1 activation
(Turgeon and Houenou, 1999).
Removal of embryonic limb buds eliminates the target skeletal muscle cells for the lumbar
spinal cord motoneurons and subsequently eliminates the multiple neurotrophic factors
necessary for neuronal survival.  Caldero et al. (1998) demonstrated that following limb bud
removal in the chick embryo approximately 90% of motoneurons die in comparison to the
40-70% that die during normal programmed cell death events.  Interestingly, grafting an
extra limb onto a chick embryo reduces motoneuron death below the normal range (Milligan
et al., 1994).  Thus, the presence of growth factors plays a significant role in controlling
motoneuron apoptosis.  Therefore, it is possible that the motoneuron cell death observed
following activation of PAR-1 in vivo is partly due to a loss of target skeletal muscle cells,
since PAR-1 is localized to skeletal muscle cells during neuromuscular junction formation
(Lanuza et al., 2003).
It is very possible that the neurotrophic rescue pathway and the thrombin death pathway
have overlapping second messengers at some point(s) in their respective signal cascades
(for review see, Turgeon and Houenou, 1999).  The rescue pathway theoretically prevails by
canceling the action of a second messenger in the death pathway. Evidence suggests that the
rescue pathway may accomplish this by increasing the amount of certain intracellular caspase
inhibitors (Perrelet et al., 2002) perhaps initiated in certain situations by increased Ca2+i
concentrations.
The goal of this study was two-fold – first, to determine whether PAR-1 activation altered
Ca2+i concentrations and second, to determine whether PAR-1 activation altered skeletal
muscle cell survival. Chick lumbar motoneuron cultures treated with chicken muscle extract
(CMX; positive control), NTFs (CNTF or BDNF), thrombin (+/- CMX or either NTF), or
the synthetic PAR-1 activating peptide, SFLLRNP (+/- CMX or either NTF) were assessed
for changes in Ca2+i.  Chick embryos were also treated with SFLLRNP to access any changes
in neurotrophic factor (BDNF, CNTF) concentrations and the number of surviving hindlimb
skeletal muscle cells.
MATERIALS AND METHODS
Motoneuron cultures. Fertilized chicken (Gallus gallus) eggs were obtained from the
Morgan Poultry Center at Clemson University (Clemson, SC) and incubated through
embryonic day five (E5) at 37° C (Percival Scientific 36 Series incubator).  Motoneurons
were isolated and purified through careful dissection and differential centrifugation through
metrizamide (Sigma, St. Louis, MO) and BSA (Sigma) gradients (Milligan et al., 1994).
The ventral portion of embryonic chick lumbar spinal cords were sub-dissected from E5
embryos, dissociated in a 30 mM suberimidate (Sigma) solution (200 mg dimethyl
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suberimidate dihydrochloride, 1M KOH, 85% 0.1M TRIS, and 1%DMSO), and loaded onto
a 6.8% metrizamide (w/v in culture medium; Sigma).  After centrifugation at 200 x g
(Beckman Centrifuge) for 15 min, large cells, i.e. motoneurons, remained in the top half of
the gradient, whereas smaller cells, such as interneurons and glial cells, would sediment in a
pellet at the bottom of the tube.  Motoneurons were collected and grown at a density of
2,000 cells/ml in a defined serum-free medium (Leobovitz’s L-15 medium; Gibco,
Gaithersburg, MD) supplemented with sodium bicarbonate (25 mg/ml; Sigma), glucose
(20mM; Sigma), progesterone (2x10-8M; Sigma), sodium selenite (3x10-8M; Sigma),
conalbumin (0.1 mg/ml; Sigma), putrescine (10-4M; Sigma), and penstrep (Gibco, Carlsbad,
CA).  The motoneurons were allowed to adhere to the plates for 2 hrs in the incubator before
the addition of complete L-15 medium and the appropriate treatments. Culture dishes were
pre-treated with the ECM components, 1% laminin (Sigma) and 0.15% poly-D-ornithine
(Sigma), to mimic an in vivo system.
Thrombin administration to the assigned dishes resulted in final concentrations of 10
nM and 100 nM (Sigma).  CMX prepared following the protocol previously described by
Oppenheim et al. (1993) was added to achieve a final concentration of 14ng/?l in the
appropriate cultures.  Finally, BDNF or CNTF (Gibco) was added to appropriate cultures to
produce a concentration of 20 ng/ml.  In all, 12 cultures were established.  After addition of
treatments, the cultures were incubated for approximately 24 hours at 37° C and 5% CO2.
Intracellular calcium assay. Intracellular Ca2+ was measured using Sigma Kit 587-M.
The working solution from the kit was made per instructions, and 1 ml of this solution was
added to 2.9 ml polystyrene cuvettes.  Just prior to the assay 1,000 living cells were collected
from each of the treatment groups and placed in a 15 ml centrifuge tube. In order to lyse the
motoneurons and release Ca2+i, 20 ìl of 0.1% Triton x-100 was added to each centrifuge tube
for 2 minutes.  Then, 10 ì l  of medium from each culture was pipetted into a cuvette containing
the working solution.  In addition to samples from the 12 cultures, one cuvette contained 10
ìl of dH2O to be used as a blank, one cuvette contained 10 ì l of a 2.50 mM Ca
2+ standard
(Sigma), and one cuvette contained 10 ì l of only complete L-15 medium.
A diode-array spectrophotometer (Hewlett-Packard 8453) was used to determine the
absorbance of each sample at a wavelength of 575 nm.  Absorbance values were then used to
calculate actual Ca2+ concentrations with this equation: [Ca2+] = (absorbance of sample/
absorbance of Ca2+ standard) x [Ca2+ standard].  Results were analyzed using a 95% confidence
interval, one-way ANOVA and a Tukey’s post-hoc test.
Hindlimb skeletal muscle histology.  Fertilized Gallus gallus eggs were incubated at
37° C.  On E3, small windows were cut into the shells and covered with clear tape to prevent
contamination.  Beginning on E5, 200 ìl of 100 ìM SFLLRNP (a concentration previously
shown to induce avian motoneuron apoptosis in ovo [Turgeon et al., 1999]; Bachem, Torrance,
CA; in 1x PBS) was added daily to embryos in the experimental group.  Control embryos
received 200 ìl of 1x PBS.  On E10, the embryos were sacrificed and the right hindlimbs
were carefully removed to ensure that each one was cut at the uppermost portion of the hip
joint; toes were left intact.  The limbs were placed into Carnoy’s fixative (Fisher Scientific,
Atlanta, GA) for 24 hours, after which they were placed into 70% ethanol for at least 24
hours.  The limbs were paraffin embedded, serially sectioned into 10 ìm slices using a rotary
microtome (American Optical820, Cambridge Scientific Products, Cambridge, MA), and
stained with hemotoxylin and eosin. Each slide was coverslipped using Permount (Fisher
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Scientific) and allowed to dry for 24 hours.  Then, the three midpoint slices of each limb
were examined and the number of skeletal muscle cells were determined at 400x
magnification.  Results were analyzed using an independent t-test with a 95% confidence
interval.
Protein isolation and western blot analysis.  In ovo embryos were treated as described
above with either SFLLRNP or PBS.  Hindlimb muscles from E10 chicks were removed at
the hip joint.  Proteins were extracted using lysis buffer containing aprotonin (Sigma) and
leupeptin (Sigma) to prevent protein degradation.  Cytosolic proteins (i.e., serine proteases)
were isolated from the membrane-bound proteins (i.e., PARs) using differential centrifugation.
Following separation, total protein concentration for the cytosolic proteins were determined
using a Bradford Assay (Sigma) and UV-Diode Array Spectrophotometer (Hewlett Packard)
to ensure equal protein loading during the separation procedure.  Proteins were separated
with a 10-20% SDS-PAGE (Cambrex, Walkersville, MD) and transferred to nitrocellulose
paper.  The transferred proteins were then immunoblotted with specific antibodies to CNTF
and BDNF (R&D Systems, Minneapolis, MN).  Quantitative analysis of the protein bands
were determined using the Kodak Gel Documentation System.
RESULTS
Cytoplasmic intracellular calcium levels are not altered following PAR-1 activation.
One-way ANOVA and a Tukey’s post-hoc test of motoneuron cultures did not reveal any
significant differences in the mean Ca2+i concentrations between the groups treated with
PAR-1 agonists, CNTF or the control (p = 0.06; Table 1), whereas CMX and BDNF both
significantly increased Ca2+i (p=0.02).  Microscopic analysis of simultaneously established
motoneuron cultures confirmed that PAR-1 was activated through the observation of increased
neuronal cell death and that the CMX, BDNF, and CNTF were functional through the
observation of decreased neuronal cell death (data not shown).
Table 1. Mean cytosolic calcium concentrations of motoneurons assayed 24 hrs following PAR-1
activation and/or treatment with neurotrophic factors (n=3).
Treatment [Ca2+i] mM + SE
Control (no treatment) 1.17430 + 0.12434
100nM Thrombin* 1.03081 + 0.50978
100µM SFLLRNP* 1.02332 + 0.51460
14ng/µl CMX** 2.33550 + 0.37340***
20ng/ml CNTF** 1.02232 + 0.52446
20ng/ml BDNF** 2.34751 + 0.67231***
Thrombin + CMX 2.31344 + 0.55132***
Thrombin + CNTF 1.02433 + 0.53372
Thrombin + BDNF 2.37754 + 0.57993***
SFLLRNP + CMX 2.33388 + 0.63429
SFLLRNP + CNTF 1.00657 + 0.53382***
SFLLRNP + BDNF 2.44385 + 0.55297***
*Final concentration of thrombin or SFLLRNP added to E5 chick motoneuron cultures
**Represents the stock concentration, which was added in 80ml volumes
***p< 0.02 vs. control, thrombin, and SFLLRNP treated groups
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Neither target skeletal muscle cells nor muscle-derived growth factors are altered
following PAR-1 induced motoneuron cell death. Following SFLLRNP-induced
motoneuron cell death no significant difference in muscle cell number existed between the
groups treated with SFLLRNP or PBS (control; p = 0.365; Fig 1).
Furthermore, using SDS-PAGE and western blot analysis there were no detectable
differences in CNTF or BDNF production following SFLLRNP treatment (Table 2).
Figure 1.  Mean number (+ SEM) of iliotibialis muscle cells - as observed in cross-section from
E10 chick hindlimbs.  Embryos were given a daily dose beginning on E5 of either 200 ìL of 100
ìM SFLLRNP or 200 ìL of 1x PBS.  All muscle cells within the most centralized region of three
midpoint sections were counted at 400x magnification.  A Student’s t-test revealed no significant
































Table 2. Quantification of neurotrophic factors from E10 chick hindlimb skeletal muscle before
and after PAR-1 activation with SFLLRNP*
Neurotrophic Factor Concentration (mg/ml)
Before PAR-1 Activation After PAR-1 Activation
           CNTF 3.144 3.110
           BDNF 4.526 4.563
*Total proteins from the right hindlimb of 20 embryos were removed, separated on a 4-12% tris-
glycine gel, and quantified by the Kodak Gel Documentation System that compares the number of
pixels in the standard lane bands to those of interest in the experimental lanes. n=3.
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DISCUSSION
Cytoplasmic intracellular calcium levels are not altered following PAR-1 activation.
The Ca2+i assay of the motoneuron cultures provided no statistical evidence that Ca
2+
i plays
a role in the avian PAR-1-induced apoptosis-signaling pathway (Table 1).  Since no significant
changes in Ca2+i concentrations were observed, the calcium set-point hypothesis cannot yet
be extrapolated to explain PAR-1 induced motoneuron cell death and suggests that IP3 is not
the second messenger employed following avian neuronal PAR-1 activation.  Furthermore,
previous studies have also failed to link CNTF activity to changes in Ca2+i (Stoop and Poo,
1996; Peterson and Brudin, 1999), whereas BDNF (Stoop and Poo, 1996) and CMX, which
contains BDNF, were expected to increase Ca2+i levels confirming the efficacy of the assay.
There are several possibilities to explain why Ca2+i concentrations did not significantly
change following PAR-1 activation. As mentioned previously, Tong et al. (1996) and Koike
and Tanaka (1991) linked altered Ca2+i concentrations with sensory and sympathetic neuronal
apoptosis most likely from the release of Ca2+ from the ER via PLC and IP3.  Furthermore,
Smirnova at al. (1998) provided another important link by demonstrating that PAR-1 directly
caused both short- and long-term elevation of Ca2+i in murine motoneurons via G proteins.
They hypothesized that the elevated calcium levels were sufficient to cause cell death.
However, since all of the research into the neuronal PAR-1 second messenger pathway has
been performed in mammalian species and/or non-motoneurons, it is possible that the avian
motoneuron PAR-1 acts through a different pathway.
Another possibility is that the Ca2+i assay accurately determined the concentration of
free calcium ions, but that the apoptosis signaling process caused Ca2+i to be bound or
sequestered.  Often when Ca2+i functions as a second messenger, it binds strongly with
calmodulin.  The complex then functions itself as part of the signal cascade, often activating
gene transcription factors via kinases (Lodish et al., 2000).  Thus, free calcium ions are
removed from the cytoplasm.  Rosenthal et al. (1998) determined that apoptosis in
keratinocytes depended on Ca2+-calmodulin second messengers.  Therefore, further studies
are underway to examine the relationship between calmodulin levels and PAR-1 activation
in avian motoneurons.  Also, recent evidence demonstrates that mitochondria are able to
sequester excess Ca2+i from the cytoplasm (Kruman and Mattson, 1999) suggesting the
possibility that Ca2+i concentrations increased prior to the 24-hr assay but were not detected
due to sequestering by the mitochondria.
It is also possible that previously observed increases in Ca2+i concentrations were not due
to release from the ER but instead from ions entering the cell via membrane channels.  Smith-
Swintosky et al. (1995b) demonstrated that thrombin-induced death in rat hippocampal
neurons corresponded with increased Ca2+i concentrations.  However, when the neurons were
cultured in a Ca2+-free medium, thrombin did not cause cell death.  Ubl et al. (1998) produced
evidence that increased Ca2+i concentrations in astrocytes resulted from both the release of
Ca2+ from intracellular stores and entry through the cell membrane.  These observations
indicate that a signal cascade independent of PLC and IP3 at least partially accounts for Ca
2+
i
flux in certain cell types. Since our cultures are grown in a relatively low Ca2+ concentration
medium the decreased availability of extracellular calcium may partially account for the
insignificant differences in Ca2+i concentrations.  We are currently trying to determine what
levels of calcium can be added to our medium to investigate this possibility without
confounding the normal viability of the avian motoneurons.
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A last possibility is that Ca2+i is not part of the PAR-1 –induced apoptosis cascade at all.
There are several other potential signal pathways that can be initiated by a PAR linked to G
proteins.  One of these is the adenylate cyclase (AC)-cyclic AMP (cAMP) pathway where
the G protein subunit activates AC to synthesize cAMP.  The cAMP serves as a powerful
second messenger that activates many cytoplasmic proteins and can alter gene expression.
Activation of PAR-1 by SFLLRNP has been shown to decrease cAMP concentrations (Salman
et al., 2003).  One intriguing possibility is that both cAMP and Ca2+i might be part of the
apoptosis cascade.  Nichols et al. (2001) stated that Ca2+-calmodulin complexes can regulate
the activity of adenylate cyclase, and thus alter levels of cAMP.  Thus, if Ca2+-calmodulin
complexes are determined to be altered during PAR-1 activation the next step would be to
investigate the activity of adenylate cyclase.
In addition, Snider (1986) stated that neuroblastoma cells treated with thrombin
experienced increased cyclic GMP synthesis that corresponded with increased activity of
phospholipase A2 and creation of arachidonic acid.  While Ellis et al. (1999) reported that
activation of PAR-1 inhibited phosphorylation of MAP kinase in endothelial cells.  Thus,
PAR-1 is apparently capable of initiating several different cascades in multiple cell types.
Neither target skeletal muscle cells nor muscle-derived growth factors are altered
following PAR-1 induced motoneuron cell death.  In agreement with Lubischer and Arnold
(1995), we surmised that if muscle-derived growth factors had been unable to rescue the
motoneurons from the SFLLRNP administration, then skeletal muscle atrophy and death
would have occurred in the absence of innervation.  Previous studies have shown that prior
or co-treatment of motoneurons with muscle-derived growth factors and PAR-1 agonists
inhibited PAR-1 induced motoneuron cell death (Turgeon et al., 1999), suggesting that skeletal
muscle targets and/or growth factor levels were unchanged despite the previous localization
of PAR-1 to skeletal muscle cells (Lanuza et al., 2003).  This present study verified this
hypothesis.  There was no significant difference in hindlimb muscle cell number (Fig. 1) or
growth factor concentrations (Table 2) between embryos treated with SFLLRNP and control
embryos. Thus, it appears that muscle-derived growth factor availability is unaltered and
remains present to perhaps partially override PAR-1 induced cell death.  Preliminary studies
from this lab indicate an increase in motoneuron cell death following simultaneous NTF
inhibition and PAR-1 activation, above the motoneuron cell death observed with PAR-1
activation alone (unpublished results).
The medical implications of understanding how thrombin and/or PAR-1 activation causes
motoneurons to die are of utmost significance.  Both spinal cord trauma and hemorrhagic
stroke rupture the blood-brain barrier causing blood to come into direct contact with nervous
tissue, exposing neurons to huge amounts of thrombin.  The delicate balance between
thrombin and its inhibitors (serpins) in the nervous tissue is then altered.  It is likely that
much of the damage from these injuries results from neuronal death caused by thrombin;
furthermore, thrombin inhibits neuronal regeneration by instigating an inflammatory response
at injury sites (Nishino et al., 1993).
Many discoveries have established strong links between apoptosis, thrombin, and
Alzheimer  0 #¡–s disease.  One of the classic characteristics of Alzheimer  0  #¡–s
is the accumulation of extracellular plaques composed primarily from â-amyloid protein
(Aâ), which causes neuronal apoptosis both in vitro and in vivo (Loo et al., 1993; LaFerla et
al., 1995).  In addition, thrombin and PN-1 (serpin) are also plaque components (Akiyama
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et al., 1992; Smith-Swintosky et al., 1995a) and past experiments have demonstrated that
thrombin increases neuronal susceptibility to Aâ-induced apoptosis, while PN-1 has a
protective effect (Mattson et al., 1993).  Since Aâ aggregations also increased Ca2+i
concentrations in neurons (Smith-Swintosky et al., 1995b), perhaps both Aâ and thrombin
work in synergy to raise Ca2+i and trigger apoptosis.  These findings are of fundamental
importance to understanding the disease, since its cognitive symptoms are caused by a loss
of neurons in the cerebral cortex, amygdala, and hippocampus (LaFerla et al., 1995).
PAR-1 agonists may also play a role in the development of amyotophic lateral sclerosis
and/or spinal muscle atrophy, since activation of this receptor results in motoneuron cell
death (Turgeon et al., 1998, 1999), the population of cells targeted by these diseases.  By
ascertaining the complete intracellular signal cascade by which activated PAR-1 commits
motoneurons to apoptosis, it may then be possible to discover methods of blocking this
signal.
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